AI biotechnology and personalized therapeutics
Recent window: last 5.2 months (2026-04-26 → 2026-10-02), compared with the prior 5.2 months.
These products apply artificial intelligence and biological modeling to drug discovery, clinical trial workflows, and personalized treatments like peptides and probiotics. They are primarily used by biotech researchers, pharmaceutical teams, and health-conscious consumers seeking tailored biological interventions. This cluster is distinguished by its scientific focus on therapeutics and life sciences rather than general digital health or administrative medical software.